Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment.

Mischkulnig, Mario; Hopp, Benjamin; Wadiura, Lisa I; Khalaveh, Farjad; Kiesel, Barbara; Rössler, Karl; Widhalm, Georg; Dorfer, Christian

Mischkulnig, Mario; Hopp, Benjamin; Wadiura, Lisa I; Khalaveh, Farjad; Kiesel, Barbara; Rössler, Karl; Widhalm, Georg; Dorfer, Christian.

Afiliación

Mischkulnig M; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Hopp B; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Wadiura LI; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Khalaveh F; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Kiesel B; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Rössler K; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Widhalm G; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Dorfer C; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.

PLoS One ; 18(6): e0287993, 2023.

Article en En | MEDLINE | ID: mdl-37390078

Asunto(s)

COVID-19; Glioma; Humanos; Pandemias; Tiempo de Tratamiento; Estudios Retrospectivos; COVID-19/epidemiología; Glioma/cirugía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Glioma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google